{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:00:35Z","timestamp":1789984835029,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2021Y9223"],"award-info":[{"award-number":["2021Y9223"]}]},{"name":"the Guiding Project of Fujian Provincial Science and Technology Plan","award":["2025Y0044"],"award-info":[{"award-number":["2025Y0044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61013-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:31:27Z","timestamp":1783330287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of DeepSeek-V3.2 and ChatGPT-5.2 in the outpatient diagnosis and treatment of prostate cancer: a multicenter evaluation of application value and multilingual adaptability"],"prefix":"10.1038","volume":"16","author":[{"given":"Chaoxiong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"61013_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"61013_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford, P. et al. Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur. Urol. 86, 148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027 (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG.","journal-title":"Eur. Urol."},{"key":"61013_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki, D. et al. Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur. Urol. 86, 164\u2013182. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.010 (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG.","journal-title":"Eur. Urol."},{"key":"61013_CR4","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41591-023-02448-8","volume":"29","author":"AJ Thirunavukarasu","year":"2023","unstructured":"Thirunavukarasu, A. J. et al. Large language models in medicine. Nat. Med. 29, 1930\u20131940. https:\/\/doi.org\/10.1038\/s41591-023-02448-8 (2023).","journal-title":"Nat. Med."},{"key":"61013_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jama.2023.1044","volume":"329","author":"A Sarraju","year":"2023","unstructured":"Sarraju, A. et al. Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model. Jama 329, 842\u2013844. https:\/\/doi.org\/10.1001\/jama.2023.1044 (2023).","journal-title":"Jama"},{"key":"61013_CR6","doi-asserted-by":"publisher","first-page":"1338215","DOI":"10.3389\/fpubh.2023.1338215","volume":"11","author":"SS Alotaibi","year":"2023","unstructured":"Alotaibi, S. S., Rehman, A. & Hasnain, M. Revolutionizing ocular cancer management: a narrative review on exploring the potential role of ChatGPT. Front. public. health. 11, 1338215. https:\/\/doi.org\/10.3389\/fpubh.2023.1338215 (2023).","journal-title":"Front. public. health"},{"key":"61013_CR7","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/cncr.35307","volume":"130","author":"L Kolla","year":"2024","unstructured":"Kolla, L. & Parikh, R. B. Uses and limitations of artificial intelligence for oncology. Cancer 130, 2101\u20132107. https:\/\/doi.org\/10.1002\/cncr.35307 (2024).","journal-title":"Cancer"},{"key":"61013_CR8","doi-asserted-by":"publisher","unstructured":"Tini, P. et al. Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study. J. Neurooncol. 176 (13). https:\/\/doi.org\/10.1007\/s11060-025-05254-z (2025).","DOI":"10.1007\/s11060-025-05254-z"},{"key":"61013_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/1471-0528.70095","volume":"133","author":"M Pavone","year":"2026","unstructured":"Pavone, M. et al. Assessing the Accuracy of Large Language Models on European Guidelines for Cervical Cancer: An In Silico Benchmarking Study. BJOG: Int. J. Obstet. Gynecol. 133, 771\u2013778. https:\/\/doi.org\/10.1111\/1471-0528.70095 (2026).","journal-title":"BJOG: Int. J. Obstet. Gynecol."},{"key":"61013_CR10","doi-asserted-by":"publisher","first-page":"111175","DOI":"10.1016\/j.ejso.2025.111175","volume":"52","author":"L Zhao","year":"2026","unstructured":"Zhao, L. et al. Exploration of the assessment of clinical decision-making capabilities in Clinical Oncology based on generative large language models. Eur. J. Surg. oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol. 52, 111175. https:\/\/doi.org\/10.1016\/j.ejso.2025.111175 (2026).","journal-title":"Eur. J. Surg. oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol."},{"key":"61013_CR11","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1245\/s10434-025-18492-2","volume":"33","author":"R Li","year":"2026","unstructured":"Li, R. et al. Evaluating the Clinical Competence of Large Language Models in Prostate Cancer Management: A Comparative Study of DeepSeek-R1 and ChatGPT. Ann. Surg. Oncol. 33, 1858\u20131869. https:\/\/doi.org\/10.1245\/s10434-025-18492-2 (2026).","journal-title":"Ann. Surg. Oncol."},{"key":"61013_CR12","doi-asserted-by":"publisher","first-page":"1721308","DOI":"10.3389\/fpubh.2025.1721308","volume":"13","author":"J Zhang","year":"2025","unstructured":"Zhang, J., Li, D., Wang, X., Wu, Z. & Lyu, Q. Application and challenges of DeepSeek in primary care in China. Front. public. health. 13, 1721308. https:\/\/doi.org\/10.3389\/fpubh.2025.1721308 (2025).","journal-title":"Front. public. health"},{"key":"61013_CR13","doi-asserted-by":"publisher","unstructured":"Jin, I. et al. DeepSeek vs. ChatGPT: prospects and challenges. Front. Artif. Intell. 8 https:\/\/doi.org\/10.3389\/frai.2025.1576992 (2025).","DOI":"10.3389\/frai.2025.1576992"},{"key":"61013_CR14","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1038\/s41591-025-03953-8","volume":"31","author":"V Sounderajah","year":"2025","unstructured":"Sounderajah, V. et al. The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence. Nat. Med. 31, 3283\u20133289. https:\/\/doi.org\/10.1038\/s41591-025-03953-8 (2025).","journal-title":"Nat. Med."},{"key":"61013_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","volume":"23","author":"DE Spratt","year":"2025","unstructured":"Spratt, D. E. et al. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J. Natl. Compr. Canc Netw. 23, 469\u2013493. https:\/\/doi.org\/10.6004\/jnccn.2025.0052 (2025).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"61013_CR16","unstructured":"Chinese Urological Association, Chinese Urologists Association & Chinese Anti-Cancer Association Genitourinary Oncology Committee. Guidelines for diagnosis and treatment of prostate cancer in Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases (eds Huang, J. & Zhang, X., 2022 edn) 130\u2013216 (Science Press, 2022)."},{"key":"61013_CR17","unstructured":"Chinese Society of Clinical Oncology Guideline Working Committee. Guidelines of Chinese Society of Clinical Oncology (CSCO) Prostate Cancer (2025 edn) (People\u2019s Medical Publishing House, 2025)."},{"key":"61013_CR18","doi-asserted-by":"publisher","unstructured":"Tam, T. Y. C. et al. A framework for human evaluation of large language models in healthcare derived from literature review. NPJ Digit. Med. 7 https:\/\/doi.org\/10.1038\/s41746-024-01258-7 (2024).","DOI":"10.1038\/s41746-024-01258-7"},{"key":"61013_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41586-023-06291-2","volume":"620","author":"K Singhal","year":"2023","unstructured":"Singhal, K. et al. Large language models encode clinical knowledge. Nature 620, 172\u2013180. https:\/\/doi.org\/10.1038\/s41586-023-06291-2 (2023).","journal-title":"Nature"},{"key":"61013_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41591-024-03423-7","volume":"31","author":"K Singhal","year":"2025","unstructured":"Singhal, K. et al. Toward expert-level medical question answering with large language models. Nat. Med. 31, 943\u2013950. https:\/\/doi.org\/10.1038\/s41591-024-03423-7 (2025).","journal-title":"Nat. Med."},{"key":"61013_CR21","doi-asserted-by":"publisher","unstructured":"Carl, N. et al. Large language model use in clinical oncology. NPJ precision Oncol. 8 https:\/\/doi.org\/10.1038\/s41698-024-00733-4 (2024).","DOI":"10.1038\/s41698-024-00733-4"},{"key":"61013_CR22","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.2147\/cmar.S220976","volume":"12","author":"R Berardi","year":"2020","unstructured":"Berardi, R. et al. Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management. Cancer Manage. Res. 12, 9363\u20139374. https:\/\/doi.org\/10.2147\/cmar.S220976 (2020).","journal-title":"Cancer Manage. Res."},{"key":"61013_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1172\/jci132031","volume":"130","author":"J Mateo","year":"2020","unstructured":"Mateo, J. et al. Genomics of lethal prostate cancer at diagnosis and castration resistance. J. Clin. Investig. 130, 1743\u20131751. https:\/\/doi.org\/10.1172\/jci132031 (2020).","journal-title":"J. Clin. Investig."},{"key":"61013_CR24","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/s41591-024-03097-1","volume":"30","author":"P Hager","year":"2024","unstructured":"Hager, P. et al. Evaluation and mitigation of the limitations of large language models in clinical decision-making. Nat. Med. 30, 2613\u20132622. https:\/\/doi.org\/10.1038\/s41591-024-03097-1 (2024).","journal-title":"Nat. Med."},{"key":"61013_CR25","doi-asserted-by":"publisher","first-page":"39426","DOI":"10.1038\/s41598-025-22940-0","volume":"15","author":"J Kim","year":"2025","unstructured":"Kim, J. et al. Limitations of large language models in clinical problem-solving arising from inflexible reasoning. Sci. Rep. 15, 39426. https:\/\/doi.org\/10.1038\/s41598-025-22940-0 (2025).","journal-title":"Sci. Rep."},{"key":"61013_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMoa2119115","volume":"386","author":"MR Smith","year":"2022","unstructured":"Smith, M. R. et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl. J. Med. 386, 1132\u20131142. https:\/\/doi.org\/10.1056\/NEJMoa2119115 (2022).","journal-title":"N Engl. J. Med."},{"key":"61013_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s1470-2045(23)00382-0","volume":"24","author":"F Saad","year":"2023","unstructured":"Saad, F. et al. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial. Lancet Oncol. 24, 1094\u20131108. https:\/\/doi.org\/10.1016\/s1470-2045(23)00382-0 (2023).","journal-title":"Lancet Oncol."},{"key":"61013_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/cas.16459","volume":"116","author":"M Oya","year":"2025","unstructured":"Oya, M. et al. Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. Cancer Sci. 116, 1638\u20131647. https:\/\/doi.org\/10.1111\/cas.16459 (2025).","journal-title":"Cancer Sci."},{"key":"61013_CR29","doi-asserted-by":"publisher","first-page":"e73469","DOI":"10.2196\/73469","volume":"11","author":"W Wang","year":"2025","unstructured":"Wang, W., Zhou, Y., Fu, J. & Hu, K. Evaluating the Performance of DeepSeek-R1 and DeepSeek-V3 Versus OpenAI Models in the Chinese National Medical Licensing Examination: Cross-Sectional Comparative Study. JMIR Med. Educ. 11, e73469. https:\/\/doi.org\/10.2196\/73469 (2025).","journal-title":"JMIR Med. Educ."},{"key":"61013_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/js9.0000000000003406","volume":"112","author":"Q He","year":"2026","unstructured":"He, Q. et al. From algorithms to operating room: can large language models master China\u2019s attending anesthesiology exam? A cross-sectional evaluation. Int. J. Surg. (London England). 112, 190\u2013201. https:\/\/doi.org\/10.1097\/js9.0000000000003406 (2026).","journal-title":"Int. J. Surg. (London England)"},{"key":"61013_CR31","doi-asserted-by":"publisher","first-page":"e65365","DOI":"10.2196\/65365","volume":"13","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Assessing the Role of Large Language Models Between ChatGPT and DeepSeek in Asthma Education for Bilingual Individuals: Comparative Study. JMIR Med. Inf. 13, e65365. https:\/\/doi.org\/10.2196\/65365 (2025).","journal-title":"JMIR Med. Inf."},{"key":"61013_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1109\/ichi61247.2024.00111","volume":"2024","author":"D Oniani","year":"2024","unstructured":"Oniani, D. et al. Enhancing Large Language Models for Clinical Decision Support by Incorporating Clinical Practice Guidelines. Proc. IEEE Int. Conf. Healthc. Inf. 2024, 694\u2013702. https:\/\/doi.org\/10.1109\/ichi61247.2024.00111 (2024).","journal-title":"Proc. IEEE Int. Conf. Healthc. Inf."},{"key":"61013_CR33","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Prompt engineering in consistency and reliability with the evidence-based guideline for LLMs. NPJ Digit. Med. 7 https:\/\/doi.org\/10.1038\/s41746-024-01029-4 (2024).","DOI":"10.1038\/s41746-024-01029-4"},{"key":"61013_CR34","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/s41591-023-02412-6","volume":"29","author":"S Gilbert","year":"2023","unstructured":"Gilbert, S., Harvey, H., Melvin, T., Vollebregt, E. & Wicks, P. Large language model AI chatbots require approval as medical devices. Nat. Med. 29, 2396\u20132398. https:\/\/doi.org\/10.1038\/s41591-023-02412-6 (2023).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61013-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:06:57Z","timestamp":1789981617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61013-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61013"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61013-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29299"}}